Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Bernie vs. Big Pharma

Vermont Senator Bernie Sanders has continued to rail against pharmaceutical industry pricing since losing the Democratic nomination to Hillary Clinton. With Sanders’s presidential ambitions scuppered, should the pharma industry fear the fury of a politician scorned? And what effect could a new, wildcard president have on the debate?

Go Top